Zimmer Biomet

Zimmer Biomet Unveils Latest Enhancements to ZBEdge™ Dynamic Intelligence™ at AAOS 2023 Annual Meeting

Retrieved on: 
Tuesday, March 7, 2023
Standard of care, Physician, Software, Orthopedic surgery, Walking, American Academy, Zimmer Biomet, Elective surgery, NYSE, Gait, AAOS, Dynamic Intelligent Currency Encryption, Surgeon, Patient, Benchmarking, Robotics, ROSA, Annual general meeting, Artificial intelligence, Smart, American Academy of Orthopaedic Surgeons, Mobile phone, Medical device, Nursing, Dentistry, Video game, Real News Update

WARSAW, Ind., March 7, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced plans to unveil the latest enhancements to ZBEdge™ Dynamic Intelligence™ at the American Academy of Orthopaedic Surgeon's (AAOS) 2023 Annual Meeting in Las Vegas. ZBEdge Dynamic Intelligence integrates Zimmer Biomet's digital, robotic, and implant technologies, connecting and collecting objective data throughout the entire episode of care. ZBEdge is powered to transform data into insights to empower healthcare providers and elevate the standard of care. During the meeting, being held March 7-11, the Company will share updates to mymobility® Digital Care Management Platform, ROSA® Knee and Persona IQ® The Smart Knee®, while also highlighting HipInsight™ Mixed Reality System* on the OptiVu™ Platform and Omni™ Suite Intelligent Operating Room.

Key Points: 
  • ZBEdge Dynamic Intelligence integrates Zimmer Biomet's digital, robotic, and implant technologies, connecting and collecting objective data throughout the entire episode of care.
  • ZBEdge is powered to transform data into insights to empower healthcare providers and elevate the standard of care.
  • The Zimmer Biomet booth ( #2543 ) at the AAOS 2023 Annual Meeting will feature demonstrations of the Company's orthopedic solutions and ZBEdge Dynamic Intelligence.
  • For more information about Zimmer Biomet events at AAOS 2023, visit www.zimmerbiomet.com/en/academy2023.html .

$6.7 Billion Worldwide Arthroscopy Devices Industry to 2027 - Key Players Include Arthrex, CONMED, Johnson & Johnson Services and Karl Storz

Retrieved on: 
Monday, January 30, 2023
Zimmer Biomet, Bone tumor, Smith & Nephew, Jaw, Rheumatoid arthritis, Spine, United States v. Arthrex, Inc., Hip, Ankle, Medtronic, Shoulder, Sports medicine, COVID-19, Wrist, Osteoarthritis, Arthroscopy, Elbow, Tendinopathy, DSM-IV codes, Prevalence, HD, Stryker Corporation, MI, Joint, Knee, Video game, Semiconductor, Medical imaging, Pharmaceutical industry, Potash, Growth

Looking forward, the publisher expects the market to reach US$ 6.7 Billion by 2027, exhibiting a CAGR of 8.09% during 2021-2027.

Key Points: 
  • Looking forward, the publisher expects the market to reach US$ 6.7 Billion by 2027, exhibiting a CAGR of 8.09% during 2021-2027.
  • Arthroscopy devices refer to various medical equipment and tools that are used to visualize, examine and conduct therapeutic interventions inside various joints of the body.
  • Some of the commonly used devices during arthroscopy include arthroscope, implants, fluid management systems, radiofrequency systems, visualization systems, etc.
  • What is the structure of the global arthroscopy devices market and who are the key players?

Northwest Arkansas' First Robotic Total Knee Arthroplasty in an ASC Performed by C. Kris Hanby, M.D., of Ozark Orthopaedics

Retrieved on: 
Saturday, February 4, 2023
Knee pain, Post-traumatic arthritis, 3D ultrasound, Rheumatoid arthritis, Patient, ASC, Osteoarthritis, Avascular necrosis, Knee, Zimmer Biomet, Dentistry

ROGERS, Ark., Feb. 04, 2023 (GLOBE NEWSWIRE) -- Ozark Orthopaedics surgeon C. Kris Hanby, M.D., has officially performed the first robot-assisted Total Knee Arthroplasty in a Northwest Arkansas ASC with the Zimmer Biomet ROSA® Knee System.

Key Points: 
  • ROGERS, Ark., Feb. 04, 2023 (GLOBE NEWSWIRE) -- Ozark Orthopaedics surgeon C. Kris Hanby, M.D., has officially performed the first robot-assisted Total Knee Arthroplasty in a Northwest Arkansas ASC with the Zimmer Biomet ROSA® Knee System.
  • The procedure was performed Thursday, Jan. 19, 2023, at Precision Surgical Center of Northwest Arkansas.
  • We're the first to do it in Northwest Arkansas," stated C. Kris Hanby, M.D., a board-certified orthopaedic surgeon and joint reconstruction specialist at Ozark Orthopaedics.
  • The surgery is now offered in the ASC by all of Ozark Orthopaedics' joint replacement specialists.

Elizabeth Keiley Selected as Executive Vice President and General Counsel of vTv Therapeutics

Retrieved on: 
Wednesday, February 1, 2023
Hilltop Holdings Inc., Assistant, Loyola University School of Law, Zimmer Biomet, VTV, Philosophy, Patient, Betzy Bromberg, Private practice, Wildman, General counsel, T1D, Therapy, Pharmaceutical industry, Management, Psychology, Boston College, Entasis

HIGH POINT, N.C., Feb. 01, 2023 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes (T1D), today announced the appointment of Elizabeth (Betzy) Keiley as Executive Vice President and General Counsel, effective immediately.

Key Points: 
  • HIGH POINT, N.C., Feb. 01, 2023 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes (T1D), today announced the appointment of Elizabeth (Betzy) Keiley as Executive Vice President and General Counsel, effective immediately.
  • Her years of legal expertise and deep experience in life sciences will be valuable to the vTv team,” said Paul Sekhri, President and Chief Executive Officer of vTv Therapeutics.
  • “Her decades of experience in both private practice and corporate settings make her an ideal fit for this position.
  • She joins vTv from Entasis Therapeutics Holdings Inc., where she served as General Counsel.

Zimmer Biomet to Acquire Embody, Inc.

Retrieved on: 
Thursday, January 5, 2023
Zimmer Biomet, Acquisition, Growth, Patient, RC, Guggenheim Partners, NYSE, Standard of care, Sports medicine, Surgeon, ZB, Management, Embodiment

WARSAW, Ind., Jan. 5, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it has reached a definitive agreement to acquire Embody, Inc., a privately-held medical device company focused on soft tissue healing, for $155 million at closing and up to an additional $120 million subject to achieving future regulatory and commercial milestones over a three year period. The acquisition is expected to be accretive to overall revenue growth and slightly dilutive to adjusted earnings per share in 2023.

Key Points: 
  • The acquisition is expected to be accretive to overall revenue growth and slightly dilutive to adjusted earnings per share in 2023.
  • "Embody's differentiated products and innovative pipeline in the area of sports medicine support our continued focus on and investment in high-growth markets and underscores our commitment to bringing meaningful new advances to patients and surgeons," said Bryan Hanson, Chairman, President and CEO of Zimmer Biomet.
  • "The planned acquisition of Embody is an important step in the ongoing transformation of ZB and the execution of our strategic priority to increase long-term growth and drive value creation."
  • The transaction is subject to customary closing conditions and is expected to be completed in February 2023.

The Global Dental Surgical Equipment Market is expected to grow by $2103.18 million during 2023-2027, accelerating at a CAGR of 7.53% during the forecast period

Retrieved on: 
Tuesday, January 3, 2023
M&A, HOB GmbH & Co KG, Zimmer Biomet, Dentsply Sirona, 3M, AMD, Patterson Companies, Henry Schein, Research, Retail

View original content:https://www.prnewswire.com/news-releases/the-global-dental-surgical-equi...

Key Points: 
  • This study identifies the technological advances and new product launches as one of the prime reasons driving the dental surgical equipment market growth during the next few years.
  • Also, the growing adoption of 3d printing technology by dental professionals and strategic collaborations and M&A will lead to sizable demand in the market.
  • The analyst presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
  • Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Surgical Navigation Systems Global Market Report 2022: Ukraine-Russia War Impact

Retrieved on: 
Tuesday, January 3, 2023
Organization, Intersection, Endometrial cancer, Johnson & Johnson, Surgeon, RI, 2000 Goody's Body Pain 500, Journal, Zimmer Biomet, Stryker Corporation, CT, COVID-19, Smith & Nephew, Hospital, Gynaecology, ENT, NuVasive, Bleeding, Physician, Geography, Magnetic resonance angiography, Acquisition, Siemens, Pharmaceutical industry, Medical imaging, Dentistry, Satellite navigation device, Medical device, Medtronic, Cleveland Clinic

The surgical navigation systems market is expected to grow to $10.73 billion in 2026 at a CAGR of 12.3%.

Key Points: 
  • The surgical navigation systems market is expected to grow to $10.73 billion in 2026 at a CAGR of 12.3%.
  • The main types of technologies in surgical navigation systems are electromagnetic navigation systems, optical navigation systems, hybrid navigation systems, fluoroscopy-based navigation systems, CT-based navigation systems, and others.Electromagnetic navigation system refers to the use of electromagnetic wave-assisted software to gather an image of soft tissue or cavity of the body to perform surgery.
  • The various applications include neurosurgery navigation systems, orthopedic navigation systems, ENT navigation systems, dental navigation systems, and others that are used by hospitals, physician practices, and ambulatory settings end users.
  • The surgical navigation systems market research report is one of a series of new reports that provides Surgical navigation systems market statistics, including surgical navigation systems industry global market size, regional shares, competitors with surgical navigation systems market share, detailed Surgical navigation systems market segments, market trends, and opportunities, and any further data you may need to thrive in the surgical navigation systems industry.

Korro Bio Expands Leadership Team with Key Appointments

Retrieved on: 
Tuesday, November 8, 2022
Health, Genetics, Other Science, Research, Science, Pharmaceutical, Biotechnology, People, National, Senior, Acquisition, Industry, Publication, Institute, Growth, Zimmer Biomet, Sirna, Lilly, Company, Chemistry, Tissue engineering, Indian Institute of Technology (BHU) Varanasi, RNA editing, RNA transfection, RNA, Eli Lilly and Company, Harvard Medical School, HR, Drug development, Loyola, Princeton University, University, Eli Lilly, Culture, Kora (instrument), Bio, AstraZeneca, Takeda, Therapy, Safety, Champaign County, Illinois, Management, Vaccine, Pharmaceutical industry, Technology, Moderna

Dr. Krishnamurthy arrives at Korro after serving in an Executive Director role at Eli Lilly & Company, where he was responsible for strategic direction for Lilly's genetic medicine portfolio.

Key Points: 
  • Dr. Krishnamurthy arrives at Korro after serving in an Executive Director role at Eli Lilly & Company, where he was responsible for strategic direction for Lilly's genetic medicine portfolio.
  • Ms. Engels has over 20 years of human resources leadership experience in the life science and healthcare sectors.
  • Prior to her position at Shire, Ms. Engels accumulated experience in a variety of HR leadership roles across global Fortune 100 life sciences corporations.
  • Korro is an RNA editing company focused on discovery and development of a new class of precision genetic medicines.

ZimVie Announces Launch of Next-Generation TSX™ Implant in the United States

Retrieved on: 
Thursday, November 3, 2022
Dental, NCM, SVP, MS, DDS, American Academy, Solution, GLOBE, Torque, MTX, Osteotomy, Zimmer Biomet, Osseointegration, TSX, Peri-implantitis, Life, Risk, PLLC, DAE, Efficiency, Dentistry, Medical device, Facebook, Spine

WESTMINSTER, Colo., Nov. 03, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the TSX Implant in the United States, the latest innovation in the companys platform of surgical, restorative, and digital dentistry solutions.

Key Points: 
  • WESTMINSTER, Colo., Nov. 03, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the TSX Implant in the United States, the latest innovation in the companys platform of surgical, restorative, and digital dentistry solutions.
  • TSX Implants are designed for immediate extraction and loading protocols as well as placement predictability and primary stability in soft and dense bone.
  • The TSX Implant made its debut last week at the American Academy of Periodontologys annual meeting in Phoenix, Arizona, and follows ZimVies joint launch of the T3 PRO Tapered Implant and Encode Emergence Healing Abutment in June 2022.
  • Further, I was impressed with how well the implant followed the planned path of insertion and did not track off course.

Surgical Planning Associates Unveils New Software for the HipInsight System

Retrieved on: 
Thursday, November 3, 2022
Knowledge, Software, Surgeon, Microsoft, ISO, Zimmer Biomet, X-ray, SPA, Goal, Irish Family Planning Association, Percussion section, Duke University Hospital, Medical device, Dentistry

BOSTON, Nov. 3, 2022 /PRNewswire/ -- Surgical Planning Associates (SPA) today announced the release of new surgical planning software to support the HipInsight patient-specific mixed reality guidance system for total hip arthroplasty, the only clinical solution of its kind.

Key Points: 
  • BOSTON, Nov. 3, 2022 /PRNewswire/ -- Surgical Planning Associates (SPA) today announced the release of new surgical planning software to support the HipInsight patient-specific mixed reality guidance system for total hip arthroplasty, the only clinical solution of its kind.
  • The HipInsight system is a mixed-reality solution that gives hip surgeons "x-ray vision" as they perform joint surgery.
  • Quotes from doctors using the new software include:
    "The HipInsight system represents a quantum advance in the way that surgeons perform joint replacement."
  • -- Dr. J. Scott Reid
    The HipInsight system will be displayed at the Zimmer Biomet and Surgical Planning Associates Exhibits at AAHKS in Dallas, November 3-6, 2022.